PAA 2.78% 18.5¢ pharmaust limited

Hi Jockthegreat,The average ALSFRS score on MND diagnosis is...

  1. 1,063 Posts.
    lightbulb Created with Sketch. 2152
    Hi Jockthegreat,

    The average ALSFRS score on MND diagnosis is 38.7 +/- 5.64.

    Our longest patient on the MND trial post diagnosis is 48 months.

    Relyvrio reduces the ALSFRS by minus 1.24 per month.

    The average longevity for a patient on a minus 0.6 score per month is 46.5 months. So that's nigh on 4 years

    The autophagy Monepantel affect is cumulative over time.

    MT was chatting about it from the 31 minute mark about the proposed ALSFRS scores here.


    A one point drop on the ALSFRS score equals an increased mortality of 7%.

    The ALSFRS score is not linear. So if Monepantel drops the score to a minus 0.6 units per month it doesn't mean the mortality rate is 4%.

    They will be using Bayesian statistics to get a probability distribution of the mortality rate v ALSFRS so I come up with the figure of 6 years

    Its the best I can calculate.

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950444/

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987707/


    Kpax










 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
18.5¢
Change
0.005(2.78%)
Mkt cap ! $89.95M
Open High Low Value Volume
18.5¢ 19.0¢ 18.5¢ $111.6K 601.3K

Buyers (Bids)

No. Vol. Price($)
2 169572 18.5¢
 

Sellers (Offers)

Price($) Vol. No.
19.0¢ 613756 10
View Market Depth
Last trade - 15.46pm 30/08/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.